Nephrotic Syndrome
The disease process presenting with severe hypoalbuminemia (low serum protein) and massive proteinuria (excessive high urine proteins) is nephrotic syndrome. This is a clinical diagnosis defined by the tetrad of heavy proteinuria (≥3.5 g/day in adults or ≥1.0 g/m²/day in children), hypoalbuminemia (<3.0 g/dL in adults or <2.5 g/dL in children), edema, and typically hypercholesterolemia 1.
Defining Characteristics
Nephrotic syndrome represents a pathophysiologic state where glomerular injury leads to massive urinary protein loss that overwhelms the body's compensatory mechanisms:
- Proteinuria threshold: ≥3.5 g/day (or >40 mg/m²/hour in children) 1
- Hypoalbuminemia: Serum albumin <3.0 g/dL in adults, <2.5 g/dL in children 1
- Edema: Present in approximately 60% of patients at diagnosis 2
- Hyperlipidemia: Commonly present due to increased hepatic synthesis and decreased clearance 1
Underlying Glomerular Diseases
The three most common histologic variants causing idiopathic nephrotic syndrome are 1:
In Children:
- Minimal change disease (MCD) - most common
- Focal segmental glomerulosclerosis (FSGS)
In Adults:
- Focal segmental glomerulosclerosis (FSGS) - most common primary cause
- Membranous nephropathy (MN) - most common primary cause
- Minimal change disease (less common than in children)
Secondary causes must always be excluded and include diabetes mellitus, amyloidosis, systemic lupus erythematosus, hematologic malignancies, and infections 3.
Pathophysiology
The mechanism involves loss of charge-size permselectivity of the glomerular capillary basement membrane, allowing large proteins like albumin to pass into the urine 4. The renal tubules' reabsorptive capacity is overwhelmed, leading to:
- Hypoalbuminemia: Increased hepatic synthesis and decreased catabolism fail to compensate for urinary losses 4
- Edema formation: Decreased serum oncotic pressure increases fluid flux into interstitial space, though sodium retention from intrinsic kidney processes also contributes 4
- Hyperlipidemia: Combined defect with increased hepatic VLDL synthesis and decreased removal of triglycerides 4
Clinical Significance and Prognosis
Nephrotic syndrome carries significant morbidity and mortality risk 1:
- Hypoalbuminemia increases odds of morbidity by 89% and mortality by 137% for each 1.0 g/dL decrease 1
- Proteinuria >3.8 g/day confers 35% risk of end-stage renal disease within 2 years 1
- Thromboembolism risk is markedly elevated: 29% renal vein thrombosis, 17-28% pulmonary embolism, 11% deep vein thrombosis in membranous nephropathy 1
- Four-fold increased risk of coronary heart disease compared to age-matched controls 1
- Children face increased risk of serious infections, particularly cellulitis and spontaneous bacterial peritonitis 1
Diagnostic Approach
In children <12 years: Empiric glucocorticoid trial without biopsy is appropriate, as most cases are steroid-responsive minimal change disease. Biopsy is indicated only if steroid-resistant 3.
In adults: Kidney biopsy is typically indicated for definitive diagnosis, with one important exception - positive serum anti-phospholipase A2 receptor (anti-PLA2R) antibodies are diagnostic of membranous nephropathy and may obviate biopsy 5, 3.
Red flags requiring nephrology referral and consideration of alternative diagnoses 6:
- Active urinary sediment (red/white blood cells, cellular casts)
- Rapidly increasing proteinuria
- Rapidly decreasing eGFR
- Absence of retinopathy in type 1 diabetes
- Nephrotic syndrome presentation
Key Clinical Pitfall
Not all patients with nephrotic-range proteinuria and hypoalbuminemia present with edema - approximately 40% do not have edema at diagnosis 2. However, the presence of edema is associated with worse outcomes, including higher venous thromboembolism risk, faster kidney failure progression, and higher one-year mortality 2. The diagnosis should not be dismissed based solely on absence of edema.